Gemcitabine plus erlotinib followed by capecitabine versus capecitabine plus erlotinib followed by gemcitabine in advanced pancreatic cancer: final results of a randomised phase 3 trial of the 'Arbeitsgemeinschaft Internistische Onkologie' (AIO-PK0104)

✍ Scribed by Heinemann, V.; Vehling-Kaiser, U.; Waldschmidt, D.; Kettner, E.; Marten, A.; Winkelmann, C.; Klein, S.; Kojouharoff, G.; Gauler, T. C.; von Weikersthal, L. F.; Clemens, M. R.; Geissler, M.; Greten, T. F.; Hegewisch-Becker, S.; Rubanov, O.; Baake, G.; Hohler, T.; Ko, Y. D.; Jung, A.; Neugebauer, S.; Boeck, S.

• Book ID: 126923970
• Publisher: BMJ Publishing Group
• Year: 2012
• Tongue: English
• Weight: 458 KB
• Volume: 62
• Category: Article
• ISSN: 0017-5749
• DOI: 10.1136/gutjnl-2012-302759